ADMA Biologics Inc (ADMA)
20.21
-1.26
(-5.89%)
USD |
NASDAQ |
Nov 14, 16:00
20.17
-0.04
(-0.20%)
After-Hours: 20:00
ADMA Biologics Free Cash Flow: 78.82M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 78.82M |
| June 30, 2024 | 66.12M |
| March 31, 2024 | 15.91M |
| December 31, 2023 | 3.819M |
| September 30, 2023 | -23.50M |
| June 30, 2023 | -51.39M |
| March 31, 2023 | -61.23M |
| December 31, 2022 | -73.42M |
| September 30, 2022 | -99.43M |
| June 30, 2022 | -98.97M |
| March 31, 2022 | -118.94M |
| December 31, 2021 | -125.88M |
| September 30, 2021 | -124.56M |
| June 30, 2021 | -135.09M |
| March 31, 2021 | -123.81M |
| December 31, 2020 | -114.73M |
| September 30, 2020 | -100.16M |
| June 30, 2020 | -99.02M |
| March 31, 2020 | -92.33M |
| December 31, 2019 | -80.01M |
| September 30, 2019 | -78.37M |
| June 30, 2019 | -65.54M |
| March 31, 2019 | -62.19M |
| December 31, 2018 | -64.77M |
| September 30, 2018 | -60.53M |
| Date | Value |
|---|---|
| June 30, 2018 | -58.07M |
| March 31, 2018 | -51.53M |
| December 31, 2017 | -39.95M |
| September 30, 2017 | -28.20M |
| June 30, 2017 | -22.58M |
| March 31, 2017 | -18.56M |
| December 31, 2016 | -18.34M |
| September 30, 2016 | -18.79M |
| June 30, 2016 | -16.79M |
| March 31, 2016 | -16.39M |
| December 31, 2015 | -15.44M |
| September 30, 2015 | -14.83M |
| June 30, 2015 | -16.01M |
| March 31, 2015 | -16.11M |
| December 31, 2014 | -17.03M |
| September 30, 2014 | -16.53M |
| June 30, 2014 | -14.91M |
| March 31, 2014 | -13.10M |
| December 31, 2013 | -11.08M |
| September 30, 2013 | -9.961M |
| June 30, 2013 | -9.848M |
| March 31, 2013 | -8.165M |
| December 31, 2012 | -6.904M |
| September 30, 2012 | -5.110M |
| June 30, 2012 | -3.014M |
Free Cash Flow Range, Past 5 Years
-135.09M
Minimum
Jun 2021
78.82M
Maximum
Sep 2024
-67.89M
Average
-95.65M
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics Inc | 142.60M |
| Madrigal Pharmaceuticals Inc | -438.32M |
| Assembly Biosciences Inc | 24.10M |
| TG Therapeutics Inc | -28.11M |
| Krystal Biotech Inc | 58.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.03M |
| Cash from Investing (Quarterly) | -1.098M |
| Cash from Financing (Quarterly) | -25.47M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.64% |